Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype
Gastric Cancer Apr 12, 2018
Cho CJ, et al. - Experts contemplated the expression of programmed cell death-1 (PD-1), programmed cell death ligand-1 (PD-L1), and the density of tumor-infiltrating lymphocytes (TILs) including CD3+ and CD8+ T cells, along with their prognostic significance in patients with gastric cancer with lymphoid stroma (GCLS) who were positive and negative for Epstein–Barr virus (EBV) infection. The variations in the tumor immune micro-environment between EBV+ and EBV- GCLS were disclosed through histopathological similarity, quantitative multispectral imaging. This, in turn, suggested that the underlying pathogenesis varied in these 2 disease entities. It was inferred that TIL density could serve as a prognostic marker in patients with GCLS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries